NRAS and melanoma: However, c-kit mutations, which are typically mutually exclusive of BRAF and NRAS mutations, are identified in around 3% of melanomas, particularly those derived from acral surfaces (soles, palms, and nail beds) (36%), mucosa (39%), and chronically sun-damaged sites (28%) (reviewed in Reddy et al. [85], Pham et al. [86]).